Insider Transactions in Q3 2021 at Omega Therapeutics, Inc. (OMGA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 03
2021
|
Flagship Pioneering Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,352,938
+9.53%
|
$39,999,946
$17.0 P/Share
|
|
Aug 03
2021
|
Flagship Pioneering Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
45,057,482
+50.0%
|
-
|
|
Aug 03
2021
|
David A Berry Director |
BUY
Open market or private purchase
|
Direct |
53,082
+50.0%
|
$902,394
$17.0 P/Share
|
|
Aug 03
2021
|
Roger Sawhney Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,941
+50.0%
|
$49,997
$17.0 P/Share
|
|
Aug 03
2021
|
Invus Public Equities, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
875,000
+27.79%
|
$14,875,000
$17.0 P/Share
|
|
Aug 03
2021
|
Invus Public Equities, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,323,530
+48.62%
|
-
|
|
Jul 30
2021
|
Invus Public Equities, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
75,000
+50.0%
|
$1,200,000
$16.14 P/Share
|